首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1533641

流式细胞技术市场规模、份额和成长分析：按技术、产品/服务、应用和地区分类 - 产业预测，2024-2031

Flow Cytometry Market Size, Share, Growth Analysis, By Technology (Cell-Based, Bead-Based), Product & Service (Instruments, Software), Application (Research, Immunology), By Region - Industry Forecast 2024-2031

出版日期: 2024年08月06日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球流式细胞技术市场规模将为39.7亿美元，从2023年的42.5亿美元成长到2031年的69.9亿美元，并将从2023年的42.5亿美元成长到2031年的69.9亿美元。 2031 年复合年增长率为7.17%）。

该行业的成长是由于癌症、免疫系统疾病和感染疾病发病率的增加。生物技术、生命科学和生物製药领域研发支出的增加推动了对流式细胞技术设备的高需求。用于照护现场(POC) 测试的微流体流式细胞技术等创新体现了此技术的进步。 COVID-19大流行进一步推动了流式细胞技术的使用。流式细胞技术提高了准确性并能够同时分析多个检体，为目前 PCR 和基于抗体的测试方法提供了可行的替代方案。因此，流式细胞技术在 COVID-19 诊断和监测中的应用正在促进该领域的发展。该领域新产品的到来凸显了儘管疫情大流行，但目前正在进行的创新。流式细胞技术提供了有关患者对 COVID-19 抗原反应的重要见解，并有助于有效的管理决策。此类技术创新的采用预计将在未来几年推动该行业的成长。此外，全球感染疾病率的上升刺激了流式细胞技术技术的采用。这些技术对于寻找免疫表型分析和细胞分离的替代方法来对抗每年夺走超过 450 万人生命的疾病至关重要。流式细胞技术可以检测环境样本中的病原微生物，已成为免疫表型分析的有效方法。

市场概况
研究用途
- 製药/生物技术
- 药物发现
- 干细胞研究
- 试管内毒性试验
免疫学
- 细胞分选
- 细胞凋亡
- 细胞週期分析
- 细胞活力
- 细胞计数
- 其他研究用途
临床应用
- 癌症诊断
- 血液学
- 自体免疫疾病
- 器官移植
- 其他临床应用
工业用途

流式细胞技术市场：依最终用户分类

市场概况
学术/研究机构
医院/临床实验室
製药和生物技术公司

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Becton, Dickinson, and Company（US）
Danaher Corporation（US）
Thermo Fisher Scientific, Inc.（US）
Agilent Technologies, Inc.（US）
Sony Group Corporation（Japan）
Bio-Rad Laboratories, Inc.（US）
Miltenyi Biotec GmbH（Germany）
Enzo Biochem, Inc.（US）
Sysmex Corporation（Japan）
BioMerieux SA（France）
Cytonome/ST, LLC（US）
Cytek Biosciences, Inc.（US）
Union Biometrica, Inc.（US）
Fluxion Biosciences, Inc.（US）
Apogee Flow Systems Ltd.（UK）
Merck KGaA（Germany）

简介目录

Product Code: SQMIG35H2031

Global Flow Cytometry Market size was valued at USD 3.97 billion in 2022 and is poised to grow from USD 4.25 billion in 2023 to USD 6.99 billion by 2031, growing at a CAGR of 7.17% in the forecast period (2024-2031).

The growth of the industry is attributed to the increasing incidence of cancer, immune system disorders, and infections. The high demand for flow cytometry instruments is driven by increased spending on R&D in the biotechnology, life sciences, and biopharmaceutical sectors. Innovations like microfluidic flow cytometry for Point-of-Care (POC) testing exemplify the advancements in this technique. The COVID-19 pandemic has further propelled the use of flow cytometry. Its enhanced accuracy and ability to analyze multiple specimens simultaneously offer a viable alternative to current PCR- or antibody-based testing methods. Consequently, the application of flow cytometry in diagnosing and monitoring COVID-19 has contributed to the sector's growth. The emergence of new products in this field highlights ongoing innovations despite the pandemic. Flow cytometry provides crucial insights into a patient's response to COVID-19 antigens, aiding in effective management decisions. The adoption of such innovations is anticipated to drive industry growth in the future. Additionally, the rising incidence of infectious diseases worldwide has spurred the adoption of flow cytometry techniques. These techniques are essential for finding alternative methods for immunophenotyping and cell isolation to combat diseases that result in over 4.5 million fatalities annually. Flow cytometry can detect pathogenic microorganisms in environmental samples, making it a viable method for immunophenotyping.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Flow Cytometry market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Flow Cytometry Market Segmental Analysis

The flow cytometry market is segmented based on Technology, Product & Service, Application, End-use, and Region. Based on Technology, the market is segmented into Cell-Based Flow Cytometry, Bead-Based Flow Cytometry. Based on Product & Service, the market is segmented into Reagents & Consumables (Antibodies, Assays & Kits, Other Reagents & Consumables), Instruments (Cell Analyzers [High-range Cell Analyzers, Mid-range Cell Analyzers, Low-range Cell Analyzers], Cell Sorters [High-range Cell Sorters, Mid-range Cell Sorters, Low-range Cell Sorters]), Services, Software, Accessories. Based on Application, the market is segmented into Research Applications (Pharmaceutical & Biotechnology [Drug Discovery, Stem Cell Research, In Vitro Toxicity Testing]), Immunology (Cell Sorting, Apoptosis, Cell Cycle Analysis, Cell Viability, Cell Counting, Other Research Applications), Clinical Applications (Cancer Diagnostics, Hematology, Autoimmune Diseases, Organ Transplantation, Other Clinical Applications), and Industrial Applications. Based on End-user, the market is segmented into Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, and Pharmaceutical & Biotechnology Companies. Based on region, the market is categorized into North America, Europe, Asia-Pacific, South America, and Middle East and Africa.

Drivers of the Global Flow Cytometry Market

Flow cytometry is essential for analyzing cell surface and intracellular molecules, characterizing diverse cell types, and assessing the purity of isolated subpopulations. The market is driven by increased R&D in multicolor assays and advanced reagents. The rising prevalence of chronic and infectious diseases, including COVID-19, has significantly boosted demand. Numerous research institutes and pharmaceutical companies are conducting extensive R&D to develop new vaccines and therapies, further fueling market growth.

Restraints in the Global Flow Cytometry Market

Flow cytometry instruments are expensive, making it difficult for many developing economies to afford technologically advanced models. These instruments typically cost between USD 75,000 and USD 100,000 for a four- to six-color, two-laser setup, creating a significant financial burden for small and medium-sized hospitals and diagnostic laboratories in these regions. For example, Thermo Fisher Scientific's Attune, a two-laser, six-color instrument, costs USD 99,000 in the United States. Consequently, the high cost of equipment is likely to limit the demand for advanced flow cytometers.

Market Trends of the Global Flow Cytometry Market

Flow cytometry is widely regarded as an excellent tool for characterizing, identifying, and isolating stem cells for both research and potential clinical applications. Recent advancements in flow cytometric hardware, reagents, and software have significantly enhanced the ability of stem cell biologists to identify and isolate rare cells. The extensive use of flow cytometry in disease diagnosis and early detection has further driven its adoption in stem cell research, thereby propelling the growth of the flow cytometry market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Start-up Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Flow Cytometry Market by Technology

Market Overview
Cell-Based Flow Cytometry
Bead-Based Flow Cytometry

Flow Cytometry Market by Product & Service

Market Overview
Reagents & Consumables
- Antibodies
- Assays & Kits
- Other Reagents & Consumables
Instruments
- Cell Analysers
- High-range cell analysers
- Mid-range cell analysers
- Low-range cell analysers
- Cell Sorters
- High-range cell sorters
- Mid-range cell sorters
- Low-range cell sorters
Services
Software
Accessories

Flow Cytometry Market by Application

Market Overview
Research Applications
- Pharmaceutical & Biotechnology
- Drug discovery
- Stem cell research
- In vitro toxicity testing
Immunology
- Cell Sorting
- Apoptosis
- Cell Cycle Analysis
- Cell Viability
- Cell Counting
- Other Research Applications
Clinical Applications
- Cancer Diagnostics
- Hematology
- Autoimmune Diseases
- organ transplantation
- Other Clinical Applications
Industrial Applications

Flow Cytometry Market by End User

Market Overview
Academic & Research Institutes
Hospitals & Clinical Testing Laboratories
Pharmaceutical & Biotechnology Companies

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Becton, Dickinson, and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sony Group Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytonome/ ST, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytek Biosciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Union Biometrica, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluxion Biosciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
Apogee Flow Systems Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beckman Coulter, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stratedigm, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nanocellect Biomedical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments